SCHEMBL1872292

SCHEMBL1872292

Cc1cc(-c2cccnc2)cn2c(C=O)cnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 7/20 0.43
CYP2E1 P05181 4/20 0.43
CYP2C9 P11712 4/20 0.43
CYP2B6 P20813 4/20 0.43
CYP2C19 P33261 4/20 0.43
AKT1 P31749 1/20 0.41
AKT2 P31751 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
CYP3A4 P08684 5/20 0.41
ERN1 O75460 3/20 0.40
MC4R P32245 1/20 0.39
SLC2A1 P11166 1/20 0.39
CHEK1 O14757 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15743223 0.80 AKT1 (0.43) CYP2A6CYP2E1CYP2C9CYP2B6CYP2C19
SCHEMBL12097947 0.76 CYP2A6 (0.43) CYP2A6CYP2E1CYP2C9CYP2B6CYP2C19
SCHEMBL1866743 0.76 PIK3CA (0.44) CYP2A6CYP2E1CYP2C9CYP2B6CYP2C19
SCHEMBL1871966 0.75 CYP11B1 (0.40) CYP2A6MKNK1MKNK2GABRG2GABRB3
SCHEMBL1871967 0.75 CYP11B1 (0.40) CYP2A6MKNK1MKNK2GABRG2GABRB3
SCHEMBL1871270 0.74 PIK3CA (0.38) AKT1AKT2MKNK1MKNK2MC4R
SCHEMBL1869444 0.74 PIK3CA (0.38) AKT1AKT2MKNK1MKNK2MC4R
SCHEMBL1870516 0.73 PIK3CA (0.40) AKT1AKT2MKNK1MKNK2
SCHEMBL1865579 0.73 FLT3 (0.42)
SCHEMBL1865829 0.72 L3MBTL1 (0.42) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741932-B2 Imidazopyridine derivatives Piramal Enterprises Limited (IN) 2014-06-03 US disclosed
US-20120232072-A1 IMIDAZOPYRIDINE DERIVATIVES PIRAMAL LIFE SCIENCES LIMITED (IN) 2012-09-13 US disclosed
EP-2496577-A1 IMIDAZOPYRIDINE DERIVATIVES Piramal Life Sciences Limited (IN) 2012-09-12 EP disclosed
WO-2011055320-A1 IMIDAZOPYRIDINE DERIVATIVES PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232072-A1 IMIDAZOPYRIDINE DERIVATIVES IL6, IL6ST, STAT3 CYP2A6 1008/4885CYP2E1 1471/4885CYP2C9 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.